A case of BRAF inhibitor-induced pancreatitis in a patient with malignant melanoma

被引：0
|
作者：
Sugiyama, Tomoko [1 ]
Fukuchi, Kensuke [1 ]
Kitauchi, Yurie [1 ]
Shimauchi, Takatoshi [1 ]
Ishida, Natsuki [2 ]
Honda, Tetsuya [1 ]
机构：
[1] Hamamatsu Univ Sch Med, Dept Dermatol, 1-20-1 Handayama,Chuo Ku, Hamamatsu, Shizuoka 4313192, Japan
[2] Hamamatsu Univ Sch Med, Dept Med 1, 1-20-1 Handayama,Chuo Ku, Hamamatsu, Shizuoka 4313192, Japan
来源：
EUROPEAN JOURNAL OF DERMATOLOGY | 2025年 / 34卷 / 05期
关键词：
D O I：
10.1684/ejd.2024.4767
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：563 / 564
页数：2
相关论文
共 50 条
  • [21] Malignant melanoma The role of BRAF inhibition in malignant melanoma
    Zaremba, A.
    Zimmer, L.
    Griewank, K. G.
    Ugurel, S.
    Roesch, A.
    Schadendorf, D.
    Livingstone, E.
    ONKOLOGE, 2020, 26 (08): : 713 - 720
  • [22] Arthralgia Induced by BRAF Inhibitor Therapy in Melanoma Patients
    Salzmann, Martin
    Benesova, Karolina
    Buder-Bakhaya, Kristina
    Papamichail, Dimitrios
    Dimitrakopoulou-Strauss, Antonia
    Lorenz, Hanns-Martin
    Enk, Alexander H.
    Hassel, Jessica C.
    CANCERS, 2020, 12 (10) : 1 - 15
  • [23] Immune Checkpoint Inhibitor-Induced (Type 3) Autoimmune Pancreatitis
    Shirwaikar Thomas A.
    Chari S.T.
    Current Gastroenterology Reports, 2023, 25 (10) : 255 - 259
  • [24] Coexistence of Immune Checkpoint Inhibitor-Induced Autoimmune Diabetes and Pancreatitis
    Zhang, Amy L.
    Wang, Fang
    Chang, Lee-Shing
    McDonnell, Marie E.
    Min, Le
    FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [25] Recurrent checkpoint inhibitor-induced warm agglutinin autoimmune hemolytic anemia in a patient with metastatic melanoma
    Hwang, Steven R.
    O'Dowd, Timothy
    Markovic, Svetomir N.
    Wolanskyj-Spinner, Alexandra P.
    AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 (07) : E169 - E171
  • [26] Presumed complement-mediated, checkpoint inhibitor-induced, thrombotic microangiopathy in a patient with metastatic melanoma
    Muniz, Thiago P.
    Patriquin, Christopher J.
    Saibil, Samuel D.
    BMJ CASE REPORTS, 2021, 14 (07)
  • [27] Cutaneous Adverse Effects of BRAF Inhibitor Therapy in Metastatic Malignant Melanoma
    Vanneste, L.
    Wolter, P.
    Garmyn, M.
    Stas, M.
    van den Oord, J.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2013, 11 : 51 - 51
  • [28] Dermatomyositis under Monotherapy with the BRAF-Inhibitor Dabrafenib in malignant Melanoma
    Vanegas, A.
    Schneider, S.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2017, 15 : 48 - 49
  • [29] A Rare Case of Sodium-Glucose Cotransporter-2 Inhibitor-Induced Acute Pancreatitis
    Haddadin, Rakahn
    Tonna, Roger F.
    Iqbal, Humzah
    Valenta, Jordan
    Iraninezhad, Homayon
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (11)
  • [30] BRAF mutations in malignant melanoma
    MacKie, RM
    Lang, J
    Boxer, M
    BRITISH JOURNAL OF DERMATOLOGY, 2003, 149 : 43 - 43
12345